What is the Efficacy of Intra-Articular Platelet-Rich Plasma Injections for Knee Osteoarthritis in Clinical Practice? A "Real-Life" Prospective Cohort.

IF 0.8 Q4 SURGERY
Leonardo Oliveira, Dominic King, Jason Genin, Anthony Miniaci, Shujaa Khan, Ignacio Pasqualini, Pedro Rullán, Evan Peck, Farah Tejpar, Gregory Gilot, Melisa Orr, George F Muschler, Nicolas S Piuzzi
{"title":"What is the Efficacy of Intra-Articular Platelet-Rich Plasma Injections for Knee Osteoarthritis in Clinical Practice? A \"Real-Life\" Prospective Cohort.","authors":"Leonardo Oliveira, Dominic King, Jason Genin, Anthony Miniaci, Shujaa Khan, Ignacio Pasqualini, Pedro Rullán, Evan Peck, Farah Tejpar, Gregory Gilot, Melisa Orr, George F Muschler, Nicolas S Piuzzi","doi":"10.52198/23.STI.43.OS1736","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Platelet-rich plasma (PRP) injections may improve symptoms in patients suffering from knee osteoarthritis. However, there is a lack of data on its effectiveness in a \"real-life\" cohort. This multi-site institutional registry study aimed to assess patients' longitudinal progress after PRP injection for knee osteoarthritis.</p><p><strong>Materials and methods: </strong>All patients receiving PRP injections for knee osteoarthritis at a large, integrated tertiary academic center (December 18, 2017 to March 1, 2021) were eligible. A prospective data collection instrument was used to collect patient demographics, procedural information, and patient-reported outcome measures. Overall, 97 patients met the inclusion criteria, and 53 were included in the analysis.</p><p><strong>Results: </strong>One in four patients (26%) improved on all three Knee Injury and Osteoarthritis Outcome Score subscales: 17% in two subscales and 20% in one subscale, respectively. Overall, 64% of patients improved in at least one patient-reported outcomes measure. At six months post injection, 49% of patients were satisfied.</p><p><strong>Conclusion: </strong>PRP injection provides positive changes in two out of three patients in different magnitudes and characteristics with careful attention to clinically meaningful differences.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical technology international","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52198/23.STI.43.OS1736","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Platelet-rich plasma (PRP) injections may improve symptoms in patients suffering from knee osteoarthritis. However, there is a lack of data on its effectiveness in a "real-life" cohort. This multi-site institutional registry study aimed to assess patients' longitudinal progress after PRP injection for knee osteoarthritis.

Materials and methods: All patients receiving PRP injections for knee osteoarthritis at a large, integrated tertiary academic center (December 18, 2017 to March 1, 2021) were eligible. A prospective data collection instrument was used to collect patient demographics, procedural information, and patient-reported outcome measures. Overall, 97 patients met the inclusion criteria, and 53 were included in the analysis.

Results: One in four patients (26%) improved on all three Knee Injury and Osteoarthritis Outcome Score subscales: 17% in two subscales and 20% in one subscale, respectively. Overall, 64% of patients improved in at least one patient-reported outcomes measure. At six months post injection, 49% of patients were satisfied.

Conclusion: PRP injection provides positive changes in two out of three patients in different magnitudes and characteristics with careful attention to clinically meaningful differences.

关节内富血小板血浆注射治疗膝关节骨性关节炎的临床疗效如何?一个“现实生活”的前瞻性队列。
富血小板血浆(PRP)注射可能改善膝骨关节炎患者的症状。然而,缺乏关于其在“现实生活”人群中的有效性的数据。这项多中心机构注册研究旨在评估膝关节骨关节炎患者注射PRP后的纵向进展。材料和方法:所有在大型综合三级学术中心(2017年12月18日至2021年3月1日)接受PRP注射治疗膝关节骨关节炎的患者均纳入研究。前瞻性数据收集工具用于收集患者人口统计资料、程序信息和患者报告的结果测量。总体而言,97例患者符合纳入标准,53例纳入分析。结果:四分之一(26%)的患者在所有三个膝关节损伤和骨关节炎结局评分亚量表上均有改善:两个亚量表分别为17%,一个亚量表为20%。总体而言,64%的患者在至少一项患者报告的结果测量中得到改善。注射后6个月,49%的患者满意。结论:PRP注射在3例患者中有2例出现不同程度和特征的阳性变化,并注意临床意义差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.00
自引率
0.00%
发文量
141
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信